المؤلفون: Shamil Haroon (5350676), Anuradhaa Subramanian (8605620), Jennifer Cooper (28261), Astha Anand (10307742), Krishna Gokhale (4768209), Nathan Byne (10307745), Samir Dhalla (10307748), Dionisio Acosta-Mena (10307751), Thomas Taverner (19905), Kelvin Okoth (10307754), Jingya Wang (3409949), Joht Singh Chandan (6931679), Christopher Sainsbury (8605625), Dawit Tefra Zemedikun (10307757), G. Neil Thomas (7418381), Dhruv Parekh (6801356), Tom Marshall (154542), Elizabeth Sapey (6011327), Nicola J. Adderley (10307760), Krishnarajah Nirantharakumar (154539)

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Immunology, Cancer, Mathematical Sciences not elsewhere classified, COVID -19, drug exposure group, angiotensin II type, CCB, Health Improvement Network, calcium channel blockers, RAS, association, care Abstract Introduction Renin-an., ACE inhibitors, CI, person-year, propensity score-matched cohort study, crude incidence rates, Severe Acute Respiratory Syndrome C., incidence rate, user, Renin-angiotensin system inhibitors, hazard ratio, ARB, all-cause mortality

Relation: https://figshare.com/articles/journal_contribution/Additional_file_2_of_Renin-angiotensin_system_inhibitors_and_susceptibility_to_COVID-19_in_patients_with_hypertension_a_propensity_score-matched_cohort_study_in_primary_care/14220900

الاتاحة: https://doi.org/10.6084/m9.figshare.14220900.v1

المؤلفون: Shamil Haroon (5350676), Anuradhaa Subramanian (8605620), Jennifer Cooper (28261), Astha Anand (10307742), Krishna Gokhale (4768209), Nathan Byne (10307745), Samir Dhalla (10307748), Dionisio Acosta-Mena (10307751), Thomas Taverner (19905), Kelvin Okoth (10307754), Jingya Wang (3409949), Joht Singh Chandan (6931679), Christopher Sainsbury (8605625), Dawit Tefra Zemedikun (10307757), G. Neil Thomas (7418381), Dhruv Parekh (6801356), Tom Marshall (154542), Elizabeth Sapey (6011327), Nicola J. Adderley (10307760), Krishnarajah Nirantharakumar (154539)

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Immunology, Cancer, Mathematical Sciences not elsewhere classified, COVID -19, drug exposure group, angiotensin II type, CCB, Health Improvement Network, calcium channel blockers, RAS, association, care Abstract Introduction Renin-an., ACE inhibitors, CI, person-year, propensity score-matched cohort study, crude incidence rates, Severe Acute Respiratory Syndrome C., incidence rate, user, Renin-angiotensin system inhibitors, hazard ratio, ARB, all-cause mortality

Relation: https://figshare.com/articles/journal_contribution/Additional_file_1_of_Renin-angiotensin_system_inhibitors_and_susceptibility_to_COVID-19_in_patients_with_hypertension_a_propensity_score-matched_cohort_study_in_primary_care/14220897

الاتاحة: https://doi.org/10.6084/m9.figshare.14220897.v1